×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACRV – acrivon therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACRV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
12:00 pm
acrv
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer [Yahoo! Finance]
Medium
Report
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer [Yahoo! Finance]
2/24
08:33 am
acrv
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/24
08:00 am
acrv
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Neutral
Report
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
2/23
08:00 am
acrv
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
Low
Report
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
2/18
08:00 am
acrv
Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
Low
Report
Acrivon Therapeutics Strengthens its Precision Medicine Therapeutics Capabilities with Launch of Internal CLIA-Certified Laboratory
1/28
09:15 am
acrv
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
Low
Report
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
1/23
08:11 am
acrv
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
Low
Report
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/27
09:00 am
acrv
Form 8-K Acrivon Therapeutics, For: Feb 27
High
Report
Form 8-K Acrivon Therapeutics, For: Feb 27
2/24
04:13 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 21 Filed by: Blume-Jensen Peter
High
Report
Form 4 Acrivon Therapeutics, For: Feb 21 Filed by: Blume-Jensen Peter
2/18
04:14 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Peterson Katharine
Low
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Peterson Katharine
2/18
04:13 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
2/18
04:12 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
Low
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
2/18
04:11 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
Low
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Devroe Eric
2/18
04:10 pm
acrv
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
Low
Report
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Blume-Jensen Peter
1/21
04:02 pm
acrv
Form 4 Acrivon Therapeutics, For: Jan 17 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Jan 17 Filed by: Miller Mary
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: